De-escalation of neoadjuvant therapy for HER2-positive early breast cancer: an overview

Ann Palliat Med. 2020 Jul;9(4):1352-1357. doi: 10.21037/apm-20-1035. Epub 2020 May 25.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Chemotherapy, Adjuvant
  • Genes, erbB-2
  • Humans
  • Neoadjuvant Therapy*
  • Treatment Outcome